News Biogen shares up after strong launch for rare disease drug US insurers are covering the treatment, despite high price.
News FDA approves Teva's Huntington's Disease drug First treatment approved for Huntington's Disease in almost a decade.
News Teva files orphan blockbuster hope in tardive dyskinesia SD-809 will be vital for Teva if approved.
News Apitope aims to bounce back from MS setback Biotech looks for funding and long-term development partner
R&D The long-delayed promise of the microbiome, with Sam Possemi... Sam Possemiers, CEO of MRM Health, believes that the microbiome space is finally coming into maturity.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
